Chris Brinsmead
Chairman
Chris Brinsmead CBE was an executive with Astrazeneca Plc, is chairman and non-executive director on many public and private boards. He has always wanted to make a difference and chairing Proveca makes a difference to childrens healthcare.
Chris wanted to be a tennis player when he grew up.
Simon Bryson
Founder, Chief Executive Officer
Simon is the CEO of Proveca, which he co-founded in 2010 following the trade sale of speciality pharma company Auralis, which he co-founded in 2005. Prior to this, Simon held a series of senior management positions in large pharma and biotech.
Simon wanted to work in a sweet shop when he grew up (inspired by Brenda, his friend’s Mum).
Helen Shaw
Founder, Director
A qualified doctor with 25 years in the pharma industry covering global medical marketing and end to end product development. Having held board positions in several pharma start-up companies Helen provides medical and clinical leadership to Proveca.
As a child, Helen wanted to be the first woman to go to the moon.
Simon Barter
Non-Executive Director
Simon is an experienced pharmaceutical professional having held several senior roles, including the head of Global Marketing capability for AstraZeneca.
Simon has lived and worked across several European countries in sales and marketing, amassing first hand experience of multiple healthcare systems.
As a child, Simon wanted to join the Navy.
Andrew Jackson
Chief Financial Officer
Andrew has worked with Proveca since its inception as Chief Financial Officer. Having qualified as an accountant in 2000. Andrew has a track record of working with several ambitious and successful healthcare and biotech companies across the UK.
As a child, Andrew wanted to be a football journalist.
Christoph Ruedig
Investor Director
Christoph represents investor AlbionVC on the board of Proveca. He’s a partner at Albion, focusing on investments in healthcare. He initially practised as a radiologist, before spending time at Bain & Company, 3i PLC and General Electric. He holds a degree in medicine and an MBA from INSEAD.
As a child, Christoph wanted to be a professional skateboarder but repeated injuries ultimately led him into medicine.
Gareth King
Investor
Gareth is an investor with Catapult Ventures. A scientist (Harvard Medical School, AstraZeneca), who moved into Business Development (Incyte, Cyprotex, Quotient) and became a CEO (Critical Pharmaceuticals). Growing up, Gareth wanted to be a musician.